The current IZTC market cap is 103.16M. The company's latest EPS is USD -0.3260 and P/E is -50.61.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 71k |
Operating Income | -1.29M | -1.33M | -1.8M |
Net Income | -1.21M | -1.4M | -2.04M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 2.35M | 2.69M | 3.56M |
Total Liabilities | 1.15M | 1.31M | 3.94M |
Total Equity | 1.2M | 1.37M | -384k |
Market Cap | 103.16M |
Price to Earnings Ratio | -50.61 |
Price to Sales Ratio | 1.45k |
Price to Cash Ratio | 1.54k |
Price to Book Ratio | -268.66 |
Dividend Yield | - |
Shares Outstanding | 6.25M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 1.51k |
52 Week Change | 48.65% |
52 Week High | 23.00 |
52 Week Low | 8.50 |
Spread (Intraday) | 5.51 (25.4%) |
Company Name | Invizyne Technologies Inc |
Address |
112 north curry street carson city, nevada 89703 |
Website | https://www.invizyne.com/ |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions